Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-026101
Filing Date
2023-06-02
Accepted
2023-06-02 16:35:13
Documents
5
Effectiveness Date
2023-06-02

Document Format Files

Seq Description Document Type Size
1 S-8 kura_s8_06-02-2023.htm S-8 162118
2 EX-5.1 kura-ex5_1.htm EX-5.1 17226
3 EX-23.1 kura-ex23_1.htm EX-23.1 3869
4 EX-FILING FEES kura-exfiling_fees.htm EX-FILING FEES 35399
5 GRAPHIC img190708051_0.jpg GRAPHIC 29364
  Complete submission text file 0000950170-23-026101.txt   260280
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

EIN.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272389 | Film No.: 23989467
SIC: 2834 Pharmaceutical Preparations